ArticleHemaSphere2026

Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.

Roch Houot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.